Getting To Zero: By Addressing LTBI in Asia
Background
Many of history’s greatest successes in the fight against preventable diseases have been characterized by momentous
shifts in people’s belief of what is possible. For too long, the world has believed that ending TB is not possible, and thatbusiness as usual will suffice. We know that neither is true! We need a paradigm shift now more than ever. The End TB
Strategy reflects this paradigm shift and must be implemented with urgency and vigour.
In 2014, WHO published Guidelines on the Management of Latent TB Infection (LTBI) along with the new End TB
Strategy which has well-defined milestones and targets to assess progress as well as 3 pillars to demonstrate ways ofmoving forward. Both represent a historic opportunity to wipe out an epidemic that has been the cause of death,illness and suffering for millennia. The strategy calls for bold policies by governments to support TB programs andemphasizes the need for active case-finding and LTBI prevention programs among high risk group, new tools,
intensified research and innovation.
The Stop TB partnership Japan is proud to host the 5th Annual Asian TB Experts meeting, which will be held in Taipei,
Taiwan on the 26th -28th August 2016. This year’s meeting will herald a new chapter in the global response to TB bybringing together low and high burden country representatives from Asia to discuss Getting to Zero: By Addressing
LTBI in Asia. Regional and international experts will convene to identify and address the challenges and best practices
that should be adapted in order to achieve the targets set by The WHO End TB Strategy.
In order for Asia to harness growing momentum behind the idea of bringing the global tuberculosis (TB) epidemic into
the elimination phase, focus on key cities and pandemics such as diabetes will be paramount. In Asia, Diabetes (DM) isa rising tide and serves as an important reservoir of TB disease and LTBI. Its impact and contribution to TB cases
surpasses HIV in most Asian countries and the syndemic is growing unabated. The consequences of diabetes onreactivation of TB and poorer outcomes on TB relapse and death despite TB treatment makes the vacuum ofawareness and action of the growing syndemic more urgent than ever. If not addressed, diabetes threatens to stall orreverse progress on the global fight against TB.
Misconceptions about the development of drug resistance following IPT still impede the scaling-up of IPT in manysettings, these and other country specific issues and approaches will be discussed and debated in the spirit of reaching
the highest ideals of better TB control.
Overarching goal: Provide a forum for international discussion and development of a consensus statement of actionneeded to achieve standards for TB screening and prevention across Asia.
Objectives: Create a forum for the presentation and discussion of:
1. Identify best practices, challenges, and opportunities in the implementation and management of LTBI in Asia.
2. Review the landscape of research including ongoing clinical trials of LTBI treatments and new diagnostic tools.
Format: Symposium combining presentations and breakout discussions leading to concrete common statement ofaction.
Disclamer: This meeting is made possible by the provision of an unrestricted grant to Stop TB Japan by Sanofi- Aventisand Qiagen.

The 5th Meeting of Asian TB Experts Community
26th -28th August 2016

Meeting Location: Grand Hyatt, Taipei Taiwan.
Chaired by: Toru Mori, MD, PhD, Executive Representative, Stop TB Partnership Japan, Director Emeritus,
Research Institute Tuberculosis (RIT), Japan Anti-Tuberculosis Association (JATA)

Getting To Zero: By Addressing LTBI in Asia
Friday 26th August 2016
19:00-21:30
Welcome reception (Canapés and Cocktails)

Location
The Residence,
2nd Floor

Getting To Zero: By Addressing LTBI in Asia
Morning Session
Saturday 27th AugustGrand Ballroom II,
3rd Floor

08:00-08:30
Registration
08:30-08:45
Welcome and opening speech
Toru Mori08:45-09:00
Welcome to Taiwan and introduction to Taiwan CDC
Steve Hsu-Sung Kuo
Objective 1: Identify best practices, challenges, and opportunities in the implementation of LTBI in Asia.
Co-Chair: Justin Denholm and Yi-Wen Huang
09:00-09:30
Paradigm shift: what is required Asia to achieve TB elimination?
Andrew Codlin
09:30-10:00
Taiwan: Experience of scaling up and implementation of LTBI testing
Anita Chanand treatment.
10:00-10:30
Asia is the epicentre of TB-DM co-infection, is targeted testing andRichard Brostrom
treatment feasible?
10:30-10:45Open Discussion
10:45--11:00
Tea BreakObjective 2: Identifying the programmatic feasibility of Diagnosis and Treatment of LTBI in Asia
Co-Chair: Camilo Roa and Timothy Barkham
Feasibility of expanding LTBI in high burden countries.
11:00-11:30
Salome Charalambous
11:30-12:00
Is there a role for Latent TB screening in high burden countries like
Prijanti SeopandiIndonesia?
12:00-12:30
Screening for LTBI in healthcare Personnel to assess TB risk- lessons
DJ Christopherfrom India
12:30-13:00
Addressing compliance with new strategy and new treatment
Hsin-Yun Sunregimens
13:00-13:10
Open Discussion
13:10-13:20
Group PhotoAll
13:20-14:20
LunchCáfe RestaurantGetting To Zero: By Addressing LTBI in Asia
Afternoon Session
Saturday 27th AugustGrand Ballroom II,3rd Floor

Objective 3: Moderated presentation and panel discussion on country experiences on the management of LTBI.
Identification of best practices, challenges, solutions, and opportunities.
Co-Chair: Ruwen Jou and Abdul Razak
Country specific presentations: 7 slides 7 min presentations from : (High Burden Countries)
14:20- 14:50
Thailand- LTBI management in HIV and child contacts <5 yearsIndonesia- LTBI Screening in Paediatric patients: The Indonesian experience
Philippines-Closing the gap between WHO guidance and policy implementation
14:50-15:20
Panel discussion session 1
Kerri Viney
15:20-15:40
Tea breakObjective 4: Moderated presentation and panel discussion on country experiences on the management of LTBI.
Identification of best practices, challenges, solutions, and opportunities.
Co-Chair: Sang Nae Cho and Umesh Gupta
Country specific presentations: 7 slides 7 min presentations from : (Low burden countries)
15:40-16:10
Singapore-Experience of Implementing nationwide contact investigations and Management of LTBI
Japan- LTBI management in the senior/ elderly population
Malaysia – LTBI management in Health Care Workers
16:10-16:50
16:50-17:00
18:00- 20:00

Panel discussion session 2
Wrap up of Day 1
Group Dinner

Richard Brostrom
Toru Mori
Peacock & Phoenix Room, 3rd Floor

Getting To Zero: By Addressing LTBI in Asia
Sunday 28th August
08:30-08:45
08:45-09:00

Welcome and housekeeping announcements
Vitamin D and TB prevention treatment trial in Mongolia

09:00- 09:15

Introduction to break out session and structured discussion.

09:15-10:15

Leveraging LTBI management to enhance TB control: case discussions

Grand Ballroom II,
3rd Floor
Toru MoriToru MoriGanmaa
Davaasambuu

Group A- Magpie Room -Blue
Group B- Swallow Room -Yellow
Group C- Swan Room -Orange
Group D- Grand Ball Room II -Green
10:15- 10:45
10:45-11:20

Tea break
Structured discussions: reflections on initiating and scaling LTBI
programs- Nominated Group presenter (10 Min) TB Busters- Magpie Room- Blue TB Ninja Warriors –Swallow Room -Yellow
 Shaolin TB Masters- Swan Room- Orange
 TB Avengers –Grand Ball room –Green

11:20- 11:30
11:30-11:45
12:00

Polling Question
Closing speech and vote of thanks
Lunch, checkout and leave at leisureToru Mori
Cáfe Restaurant